Go offline with the Player FM app!
JCO Article Insights: Simultaneous Durvalumab and CRT in Unresectable Stage III NSCLC
Manage episode 521027503 series 9910
In this episode of JCO Article Insights, host Dr. Ece Cali Daylan interviews author Dr. Jeffrey Bradley about the article, "Simultaneous Durvalumab and Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer" by Bradley, et al published October 13, 2025.
TRANSCRIPT TO COME
DISCLOSURES
Dr. Bradley Honoria: Mevion Medical Systems, Inc. Consulting or Advisory Role: Varian, Inc, Genentech, Inc. Research Funding: Varian Medical Systems
Dr. Cali Research Funding Company: BeiGene, Nuvalent, Inc., Astra Zeneca
444 episodes
Manage episode 521027503 series 9910
In this episode of JCO Article Insights, host Dr. Ece Cali Daylan interviews author Dr. Jeffrey Bradley about the article, "Simultaneous Durvalumab and Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer" by Bradley, et al published October 13, 2025.
TRANSCRIPT TO COME
DISCLOSURES
Dr. Bradley Honoria: Mevion Medical Systems, Inc. Consulting or Advisory Role: Varian, Inc, Genentech, Inc. Research Funding: Varian Medical Systems
Dr. Cali Research Funding Company: BeiGene, Nuvalent, Inc., Astra Zeneca
444 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.